跳至主要内容
临床试验/NCT01104181
NCT01104181已完成不适用

Collection of Anal Specimens for Assessment of Anal Cancer Using the HC2 High-Risk DNA Test (QIAGEN)

Laser Surgery Care1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2010年3月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
300
试验地点
1
主要终点
HC2 can accurately test for oncogenic HPV in anal specimens

研究概览

简要总结

This is a study to determine if HC2 HPV testing in the anal canal can detect high-risk HPV and whether this aids in identifying individuals are risk for anal cancer or precancerous lesions.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • male or female 18 years of age or older
  • screened for anal dysplasia, including MSM and women -

排除标准

  • subject has had a previous treatment for anal cancer.
  • subjects that have used enemas or other foreign substances, in the anal canal or anal sex within 24 hours of collection.
  • subjects that have bleeding disorders or use anticoagulation treatments. -

结局指标

主要结局

HC2 can accurately test for oncogenic HPV in anal specimens

时间窗: in approximately 12 months

Determination that HC2 testing in the anal canal can be performed

次要结局

  • Sensitivity and specificity of cytology with HC2(in approximately 12 months)

研究者

发起方
Laser Surgery Care
申办方类型
Other

研究点 (1)

Loading locations...

相似试验